Already prescribed to 7M+ patients worldwide, this GLP-1 therapy is recognised not just for glycaemic control, but also for its benefits in weight reduction, cardiovascular health, and kidney protection
Given the limited research, its use as an oral or IV skin-lightening agent during pregnancy or lactation cannot be recommended
demonstrated that reducing Gln levels, inhibiting the transmembrane transport of Gln (using V-9302), or blocking Gln metabolism (with CB-839) markedly decreased mesothelioma cell proliferation, spheroid formation, invasion, and migration
Ozempic was among the first to gain widespread recognition, though its technically approved for diabetes management
The marketing theory is tidy: ingredients absorb through the skin, appetite drops, calories fall, and weight follows
More widespread coverage is expected